Stock Price Quote

BLISS GVS PHARMA LTD.

NSE : BLISSGVSBSE : 506197ISIN CODE : INE416D01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE97.104.55 (+4.92 %)
PREV CLOSE ( ) 92.55
OPEN PRICE ( ) 95.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 153093
TODAY'S LOW / HIGH ( )93.70 101.80
52 WK LOW / HIGH ( )86 224
NSE96.904.55 (+4.93 %)
PREV CLOSE( ) 92.35
OPEN PRICE ( ) 94.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 96.90 (11726)
VOLUME 1482012
TODAY'S LOW / HIGH( ) 93.30 101.55
52 WK LOW / HIGH ( )85 221
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
S R Vaidya - Chairman S N Kamath - Managing Director
Registered Office

Address 102, Hyde Park,Saki Vihar Road,Andheri (East) ,
Mumbai,
Maharashtra-400072

Phone 022-42160000

Email info@blissgvs.com

Website www.blissgvs.com

Registrars Details
Universal Capital Securities Pvt. Ltd
(Formerly Mondkar Computers Pvt Ltd), 21 Shakil Niwas ,Opp. Satya Saibaba Temple, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE, MCX

NEWS

18Mar Clarification sought from Bliss GVS P
The Exchange has sought clarification from Bliss GVS Pharma Ltd on March..
18Mar Bliss GVS Pharma informs about clarifi
With refer to letter dated March 18, 2021, seeking clarification on pric..
05Feb Announcement under Regulation 30 (LOD
Please find enclosed herewith the reports related to the violation of Co..
22Jan Appointment of Director
inter alia,approved 1. Appointment of Mr. Gagan Harsh Sharma (DIN: 07939..
22Jan Intimation Under Regulation 30 Of The
This is with reference to the Board Meeting of the Company which was hel..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit224.57923.340000000001
Gross Profit 304.38 1217.13
Operating Profit 345.421351.01
Net Sales 1274.374419.51

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3905.70 (8.77%)
M.Cap ( in Cr)9764.25
Neuland Laboratories (BSE)
peergroup  2674.85 (7.69%)
M.Cap ( in Cr)3431.80
Dr. Reddys Lab (BSE)
peergroup  5153.95 (3.69%)
M.Cap ( in Cr)85710.82
Abbott India (BSE)
peergroup  14860.60 (1.08%)
M.Cap ( in Cr)31577.74
Pfizer (BSE)
peergroup  5480.60 (2.86%)
M.Cap ( in Cr)25072.50

Shareholding Pattern

FI/BANKS/INSURANCE 5.72%
NON-INSTITUTION 37.61%
PROMOTERS 33.31%
MUTUAL FUNDS/UTI 0.02%
GOVERNMENT 0%
FII 0%

About Bliss GVS Pharma Ltd.

Bliss GVS Pharma Ltd. was incorporated in the year 1984. Its today's share price is 97.1. Its current market capitalisation stands at Rs 1001.55 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4419.51 Cr and Total Income of Rs.4768.85 Cr. The company's management includes Gagan Harsh Sharma, Aditi Bhatt, Shruti Vishal Rao, Vibha Gagan Sharma, Shilpa Bhatia, Santosh Parab, S N Kamath, S R Vaidya.

It is listed on the BSE with a BSE Code of 506197 , NSE with an NSE Symbol of BLISSGVS and ISIN of INE416D01022. It's Registered office is at 102, Hyde Park,Saki Vihar Road,Andheri (East) Mumbai-400072, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BK Khare & Co, Kalyaniwalla & Mistry LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)